<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">83442</article-id><article-id pub-id-type="doi">10.7554/eLife.83442</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Evolutionary Biology</subject></subj-group></article-categories><title-group><article-title>The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolution</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-243886"><name><surname>Moulana</surname><given-names>Alief</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0389-7082</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-243887"><name><surname>Dupic</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-293362"><name><surname>Phillips</surname><given-names>Angela M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9806-7574</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-243888"><name><surname>Chang</surname><given-names>Jeffrey</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-294629"><name><surname>Roffler</surname><given-names>Anne A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8412-0322</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-294630"><name><surname>Greaney</surname><given-names>Allison J</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-241225"><name><surname>Starr</surname><given-names>Tyler</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6713-6904</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-4031"><name><surname>Bloom</surname><given-names>Jesse D</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1267-3408</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" corresp="yes" id="author-40694"><name><surname>Desai</surname><given-names>Michael M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9581-1150</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf6"/></contrib><aff id="aff1"><institution content-type="dept">Department of Organismic and Evolutionary Biology</institution>, <institution>Harvard University</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Physics</institution>, <institution>Harvard University</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Basic Sciences Division</institution>, <institution>Fred Hutchinson Cancer Research Center</institution>, <addr-line><named-content content-type="city">Seattle</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-41027"><name><surname>van der Meer</surname><given-names>Jos W</given-names></name><role>Reviewing editor</role><aff><institution>Radboud University Medical Centre</institution>, <country>Netherlands</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>angela.phillips@ucsf.edu</email> (AP);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>mdesai@oeb.harvard.edu</email> (MD);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>21</day><month>02</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e83442</elocation-id><history><date date-type="received"><day>21</day><month>09</month><year>2022</year></date><date date-type="accepted"><day>06</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Moulana et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Moulana et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-83442-v1.pdf"/><abstract><p>The Omicron BA.1 variant of SARS-CoV-2 escapes convalescent sera and monoclonal antibodies that are effective against earlier strains of the virus. This immune evasion is largely a consequence of mutations in the BA.1 receptor binding domain (RBD), the major antigenic target of SARS-CoV-2. Previous studies have identified several key RBD mutations leading to escape from most antibodies. However, little is known about how these escape mutations interact with each other and with other mutations in the RBD. Here, we systematically map these interactions by measuring the binding affinity of all possible combinations of these 15 RBD mutations (2<sup>15</sup> = 32,768 genotypes) to four monoclonal antibodies (LY-CoV016, LY-CoV555, REGN10987, and S309) with distinct epitopes. We find that BA.1 can lose affinity to diverse antibodies by acquiring a few large-effect mutations and can reduce affinity to others through several small-effect mutations. However, our results also reveal alternative pathways to antibody escape that do not include every large-effect mutation. Moreover, epistatic interactions are shown to constrain affinity decline in S309 but only modestly shape the affinity landscapes of other antibodies. Together with previous work on the ACE2 affinity landscape, our results suggest that escape of each antibody is mediated by distinct groups of mutations, whose deleterious effects on ACE2 affinity are compensated by another distinct group of mutations (most notably Q498R and N501Y).</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>S. cerevisiae</italic></kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000854</institution-id><institution>Human Frontier Science Program</institution></institution-wrap></funding-source><award-id>Postdoctoral Fellowship</award-id><principal-award-recipient><name><surname>Dupic</surname><given-names>Thomas</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000011</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><award-id>Hanna H. Gray Postdoctoral Fellowship</award-id><principal-award-recipient><name><surname>Phillips</surname><given-names>Angela M</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>Graduate Research Fellowship Program</award-id><principal-award-recipient><name><surname>Chang</surname><given-names>Jeffrey</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>Simons Center DMS-1764269</award-id><principal-award-recipient><name><surname>Desai</surname><given-names>Michael M</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>Harvard Quantitative Biology Initiative DEB-1655960</award-id><principal-award-recipient><name><surname>Desai</surname><given-names>Michael M</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>Harvard Quantitative Biology InitiativeGM104239</award-id><principal-award-recipient><name><surname>Desai</surname><given-names>Michael M</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>NIH/NIAID R01AI141707</award-id><principal-award-recipient><name><surname>Bloom</surname><given-names>Jesse D</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Angela M Phillips, has or has recently consulted for Leyden Labs..</p></fn><fn fn-type="conflict" id="conf3"><p>Allison J Greaney, is an inventor on Fred Hutch licensed patents related to viral deep mutational scanning.(patentnumbers WO2022146484, WO2020006494 and application number US20210147832)..</p></fn><fn fn-type="conflict" id="conf4"><p>Tyler Starr, is an inventor on Fred Hutch licensed patents related to viral deep mutational scanning.(patentnumbers WO2022146484, WO2020006494 and application number US20210147832)..</p></fn><fn fn-type="conflict" id="conf5"><p>Jesse D Bloom, is an inventor on Fred Hutch licensed patents related to viral deep mutational scanning. (patentnumbers WO2022146484, WO2020006494 and application number US20210147832).  J.D.B. has or has recently consulted for Apriori Bio, Oncorus, Moderna, and Merck..</p></fn><fn fn-type="conflict" id="conf6"><p>Michael M Desai, has or has recently consulted for Leyden Labs..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Raw sequencing reads have been deposited in the NCBI BioProject database under accession number PRJNA877045.All associated metadata are available at https://github.com/desai-lab/omicron_ab_landscape.  -</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Desai MM</collab></person-group><year iso-8601-date="2023">2023</year><source>The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolution</source><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA877045">http://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA877045</ext-link><comment>NCBI BioProject, PRJNA877045</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-83442-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>